2011 IMPACT Symposium I - Abstracts

"New Paradigms in Clinical Trial Methodology"


Home   Agenda   Abstracts   Photos


L-R: Drs. Auman, Davidian, Fine, Korn, Li, Parmigiani, Tzeng, Wang and Zeng

Todd Auman, PHD Research Assistant Professor at UNC-Chapel Hill Institute for Pharmacogenomics and Individualized Therapy “Pharmacogenomic interrogation of colorectal cancer using next-generation whole exome sequencing” [Abstract]

Liddy Chen PHD Student, UNC-Chapel Hill Department of Biostatistics “Design consideration for complex survival models” [Abstract]

Marie Davidian, PHD William Neal Reynolds Professor in the Department of Statistics and Director of the Center for Quantitative Sciences in Biomedicine at NC State University “A robust method for estimating optimal treatment regimes” [Abstract]

Jason Fine, ScD Professor, UNC-Chapel Hill Department of Biostatistics “An overview of competing risks data, with applications in clinical trials” [Abstract]

H.M. James Hung, PHD Supervisory Mathematical Statistician and Director, Division of Biometrics I, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration (FDA) “Utilities and challenges of adaptive designs in drug development” [Abstract]

Edward Korn, PHD National Cancer Institute, Biometric Research Branch, Division of Cancer Treatment and Diagnosis “Biomarker-adaptive clinical trial designs” [Abstract]

Eric Laber, PHD Assistant Professor, NC State Department of Statistics “Adaptive inference after model selection” [Abstract]

Mark Levenson, PHD Supervisory Mathematical Statistician, Food and Drug Administration (FDA) “Safety decision-making with multiple sources and different types of studies—recent examples from FDA Advisory Committees” [Abstract]

Zhiguo Li, PHD Assistant Professor, Duke University Department of Biostatistics and Bioinformatics “Fitting Cox models with doubly censored data using spline-based marginal likelihood” [Abstract]

David Madigan, PHD Professor and Chair, Columbia University Department of Statistics “Drug safety in spontaneous reports, observational databases, and clinical trials: Can we do better?” [Abstract]

Giovanni Parmigiani, PHD Professor, Harvard University Department of Biostatistics "Adaptive randomized trial design for patients with recurrent glioblastoma" [Abstract]

Jung-Ying Tzeng, PHD Associate Professor, NC State Department of Statistics “A gene-trait similarity regression method for gene-level pharmacogenetics analysis” [Abstract]

Xiaofei Wang, PHD Assistant Professor, Duke University Department of Biostatistics and Bioinformatics “Biased sampling and its applications in biomarker validation” [Abstract]

Donglin Zeng, PHD Associate Professor, UNC-Chapel Hill Department of Biostatistics “Estimating treatment effects with treatment switching via semi-competing risks models: An application to a colorectal cancer study” [Abstract]

Yingqi Zhao PHD Student, UNC-Chapel Hill Department of Biostatistics “Estimating Individualized Treatment Rules Using Outcome Weighted Learning” [Abstract]